Food import got clean chit by fssai for special medical purposes

New Delhi – The Food Safety and Standards Authority of India (FSSAI) is working on a mechanism to allow imports of products for consumers, especially children, who suffer from IEM (inborn errors of metabolism) disorders. This will be done through a special import notification in a bid to meet the nutritional needs of children who suffer from metabolism disorders. As part of its “Diet4Life initiative”, the regulator will facilitate the import of Food for Special Medical Purposes (FSMP) products soon.
These products are made by companies such as Nestle, Danone and Abbott. These disorders, which impact a small section of consumers, especially babies, occur due to single gene defect leading to abnormalities in the synthesis of proteins, carbohydrates and fats. The regulator has identified 15 IEM conditions under this project. Pawan Agarwal, CEO, FSSAI, said that the regulator is taking speedy action to create a platform and allow imports of such products in ollaborations with companies and health professionals. Under this project, four leading hospitals have been identified and the regulator is collaborating with doctors and dieticians to train them to be able to prescribe these products since diagnosis of these disorders is difficult. “Companies have also agreed to offer some of these products at subsidised rates for the next two years especially for poor patients. We are in the process of finalising this mechanism that will allow patients suffering from IEM disorders to have access to these products and this will pave the way for saving thousands of lives,” he added. Under this programme, the food regulator will also collaborate with other partners to conduct workshops to train health professionals from across the country, so they can diagnose these disorders during preliminary check-up stage and refer them for screening.
Pawan Agarwal, CEO, FSSAI, said that the regulator is taking speedy action to create a platform and allow imports of such products in ollaborations with companies and health professionals.

Related Posts

Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…

Ludhiana police seize 56 kg ganja; courier warehouse under scanner

The recovery has raised serious concerns over alleged lapses in parcel screening and monitoring within the logistics chain. The special cell of Ludhiana police has seized more than two quintals…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework